Remestemcel-L Completed Phase 2 Trials for Myocardial Infarction / Chronic Ischemic Left Ventricular Dysfunction Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02013674 | The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) |